Application of Failure Mode Effect Analysis (FMEA) to Improve Medication Safety in the Dispensing Process – A Study at A Teaching Hospital, Sri Lanka
Background: Failure Mode Effect Analysis (FMEA) is a prospective, team based, structured process used to identify system failures of high risk processes before they occur. Medication dispensing is a risky process that should be analysed for its inherent risks using FMEA.
Objectives: The objective of this study was to identify possible failure modes, their effects and causes in the dispensing process of a selected tertiary care hospital using FMEA.
Methods: Two independent teams (Team A and Team B) of pharmacists conducted the FMEA for two months in the Department of Pharmacy of a selected teaching hospital, Colombo, Sri Lanka. Each team had five meetings of two hours each, where the dispensing process and sub processes were mapped, and possible failure modes, their effects, and causes, were identified. A score for potential severity (S), frequency (F) and detectability (D) was assigned for each failure mode. Risk Priority Numbers (RPNs) were calculated (RPN=SxFxD) to prioritise identified failure modes.
Results: Team A identified 48 failure modes while Team B identified 42. Among all 90 failure modes, 69 were common to both teams. Using the RPN, Team A prioritised one failure mode, while Team B prioritised three (having identical RPNs). Both teams identified overcrowded dispensing counters as a cause for 57 failure modes. Redesigning of, dispensing tables, dispensing labels, the dispensing and medication re-packing processes, and establishing a patient counseling unit were the major suggestions for correction.
Conclusion: FMEA was successfully used to identify and prioritise possible failure modes of the dispensing process through active involvement of pharmacists.
Figure 1
Figure 2
Figure 3
Posted 12 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
Invitations sent on 11 Jan, 2021
On 09 Jan, 2021
On 08 Jan, 2021
On 08 Jan, 2021
On 24 Dec, 2020
Application of Failure Mode Effect Analysis (FMEA) to Improve Medication Safety in the Dispensing Process – A Study at A Teaching Hospital, Sri Lanka
Posted 12 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
Received 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
On 11 Jan, 2021
Invitations sent on 11 Jan, 2021
On 09 Jan, 2021
On 08 Jan, 2021
On 08 Jan, 2021
On 24 Dec, 2020
Background: Failure Mode Effect Analysis (FMEA) is a prospective, team based, structured process used to identify system failures of high risk processes before they occur. Medication dispensing is a risky process that should be analysed for its inherent risks using FMEA.
Objectives: The objective of this study was to identify possible failure modes, their effects and causes in the dispensing process of a selected tertiary care hospital using FMEA.
Methods: Two independent teams (Team A and Team B) of pharmacists conducted the FMEA for two months in the Department of Pharmacy of a selected teaching hospital, Colombo, Sri Lanka. Each team had five meetings of two hours each, where the dispensing process and sub processes were mapped, and possible failure modes, their effects, and causes, were identified. A score for potential severity (S), frequency (F) and detectability (D) was assigned for each failure mode. Risk Priority Numbers (RPNs) were calculated (RPN=SxFxD) to prioritise identified failure modes.
Results: Team A identified 48 failure modes while Team B identified 42. Among all 90 failure modes, 69 were common to both teams. Using the RPN, Team A prioritised one failure mode, while Team B prioritised three (having identical RPNs). Both teams identified overcrowded dispensing counters as a cause for 57 failure modes. Redesigning of, dispensing tables, dispensing labels, the dispensing and medication re-packing processes, and establishing a patient counseling unit were the major suggestions for correction.
Conclusion: FMEA was successfully used to identify and prioritise possible failure modes of the dispensing process through active involvement of pharmacists.
Figure 1
Figure 2
Figure 3